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Abstract
Pathogens use diverse molecular machines to penetrate host cells and manipulate intracellular vesicular trafficking. Viruses
employ glycoproteins, functionally and structurally similar to the SNARE proteins, to induce eukaryotic membrane fusion.
Intracellular pathogens, on the other hand, need to block fusion of their infectious phagosomes with various endocytic
compartments to escape from the degradative pathway. The molecular details concerning the mechanisms underlying this
process are lacking. Using both an in vitro liposome fusion assay and a cellular assay, we showed that SNARE-like bacterial
proteins block membrane fusion in eukaryotic cells by directly inhibiting SNARE-mediated membrane fusion. More
specifically, we showed that IncA and IcmG/DotF, two SNARE-like proteins respectively expressed by Chlamydia and
Legionella, inhibit the endocytic SNARE machinery. Furthermore, we identified that the SNARE-like motif present in these
bacterial proteins encodes the inhibitory function. This finding suggests that SNARE-like motifs are capable of specifically
manipulating membrane fusion in a wide variety of biological environments. Ultimately, this motif may have been selected
during evolution because it is an efficient structural motif for modifying eukaryotic membrane fusion and thus contribute to
pathogen survival.
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Introduction
In eukaryotic cells, intracellular membrane fusion events are
mediated by members of the SNARE protein family. SNAREs
are conserved in all eukaryotes and are present on the surface
of all secretory compartments [1,2,3]. During membrane fusion,
t-SNAREs present on target organelles assemble into a four-helix
bundle with the v-SNAREs present on vesicles. This event brings
the membranes in which they are embedded into close apposition
and drives bilayer fusion [4,5,6,7]. The SNARE residues
indispensable for membrane fusion form the ‘‘SNARE motif’’
[6], a 60 amino-acid sequence composed of coiled-coil heptad
repeats [Table 1 and [8]]. Similar structural motifs are used for the
same purpose by viruses, highlighting the general role of coiled coil
sequences in manipulating membrane fusion [9,10]. Here we
investigated whether this particular motif is also utilized by
bacteria to influence eukaryotic membrane fusion.
Intracellular bacteria such as Salmonella, Mycobacterium, Legionella
or Chlamydia must manipulate membrane fusion of the host cells
they inhabit in order to escape lysosomal fusion [11,12]. While
intracellular, these bacteria modify their infectious phagosomes,
also called inclusions or vacuoles, by expressing their own proteins
to the surface [13]. As a result, the infectious phagosomes become
protected against fusion with endocytic compartments [14,15].
Although the precise mechanism is unclear, it is likely that the
bacterial proteins expressed on the surface of these infectious
phagosomes are responsible for blocking fusion with the endocytic
compartments [16,17]. Interestingly, over the past few years a
growing number of SNARE-like proteins have been identified
notably in Chlamydia and Legionella [18,19,20], two intracellular
bacteria responsible for human diseases. For instance, IncA, a
protein expressed by Chlamydia on the surface of the infectious
vacuole displays two SNARE-like motifs [19,21]. IncA interacts
directly with mammalian SNAREs [21] and IncA expressed by
Chlamydia trachomatis, CtrIncA, has been implicated in homotypic
membrane fusion [22,23]. Formation of Chlamydia inclusions by
homotypic fusion is an event specifically occurring during C.
trachomatis infection. Interestingly, most Chlamydia strains express
IncA, yet not all strains have the capacity to undergo homotypic
fusion, suggesting that IncA likely plays additional roles.
Expressed by Legionella pneumophila, IcmG/DotF only displays
one SNARE-like motif. The precise function of IcmG/DotF is still
unclear, although mutants are rapidly trafficked to, and degraded
within lysosomal compartments [24]. Using these bacterial
SNARE-like proteins as our models, we tested their function on
SNARE-mediated membrane fusion. We discovered a novel
inhibitory function of these proteins and characterized the
molecular mechanism they use to block host membrane fusion.
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Results and Discussion
Intracellular bacteria primarily protect their vacuoles against
endocytic fusion [12,25], which is mediated by the association of
the v-SNARE VAMP8 with the endocytic t-SNARE composed of
Syntaxin 7, Syntaxin 8 and Vti1b [26,27].
Two distinct complementary mechanisms have been suggested
concerning chlamydial avoidance of lysosomal fusion: 1) during
the first ,8 hours of infection, the protection of the vacuole
appears to be independent of Chlamydia protein synthesis [28].
Rather, structural components of the Chlamydia cell wall seems to
be involved in this activity [29]. 2) Later however, at a time that
coincides with IncA expression [30], an active modification of the
inclusion membrane takes place to sustain the protection of the
inclusion. In light of these evidences, we started to investigate the
role of IncA in the protection of the Chlamydia inclusion.
Previously, IncA has been shown to co-precipitate with the
endocytic SNAREs when expressed in cells [21]. Using an in vitro
liposome fusion assay [4,6], we now tested both CtrIncA and
CcaIncA expressed respectively by C. trachomatis and C. caviae, for
their functional effect on endocytic SNARE-mediated membrane
fusion (see Table 2 for a description of all the SNARE proteins
studied here). To do so, we reconstituted the t-SNARE
[Syntaxin7/Syntaxin8/Vti1b] and the v-SNARE [VAMP8]
with or without IncA into acceptor and donor liposomes, respec-
tively. Donor liposomes contain the FRET pair Rhodamine-PE
[N- (lissamine rhodamine B sulfonyl) phosphatidyl ethanolamine]
and NBD-PE [N- (7-nitro-2,1,3-benzoxadiazole-4-yl) phosphatidyl
ethanolamine]. Liposome fusion results in lipid mixing of donor
and acceptor liposomes. As the distance between NBD and
rhodamine increases, the resonance energy transfer and the
quenching of NBD are reduced. Fusion becomes detectable as an
increased NBD fluorescence at 538nm [4,6]. After mixing different
combinations of t- and v- liposomes+/2IncA, liposome fusion was
allowed to proceed at 37uC for two hours. As shown in Fig. 1,
CtrIncA strongly inhibits endocytic SNARE-mediated fusion.
CtrIncA blocks membrane fusion whether present in v-SNARE
(,70% inhibition) or in t-SNARE (,37% inhibition) liposomes
Table 1. SNARE motifs alignment.
...*..*...*..*...*..*...*..*...*..*...*..*...*..*...*..*....
hSNAP25-Nterm 19 DQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKDMKEAEKNL
hSNAP25-Cterm 140 DARENEMDENLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANQRA
hSNAP23-Cterm 146 DAREDEMEENLTQVGSILGNLKDMALNIGNEIDAQNPQIKRITDKADTNRDRIDIANARA
Sec9p-Cterm 588 DEMELEIDRNLDQIQQVSNRLKKMALTTGKELDSQQKRLNNIEESTDDLDINLHMNTNRL
hStx1a 192 LSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSDT
hStx4 200 LNEISARHSEIQQLERSIRELHDIFTFLATEVEMQGEMINRIEKNILSSADYVERGQEHV
Sso1p 190 LAEVQARHQELLKLEKSMAELTQLFNDMEELVIEQQENVDVIDKNVEDAQLDVEQGVGHT Q-SNAREs
hStx5 209 DSYIQSRADTMQNIESTIVELGSIFQQLAHMVKEQEETIQRIDENVLGAQLDVEAAHSEI
Sed5p 249 NVYLQERNRAVETIESTIQEVGNLFQQLASMVQEQGEVIQRIDANVDDIDLNISGAQREL
Vam3p 190 TIIHQERSQQIGRIHTAVQEVNAIFHQLGSLVKEQGEQVTTIDENISHLHDNMQNANKQL
hStx7 165 LRLIHERESSIRQLEADIMDINEIFKDLGMMIHEQGDVIDSIEANVENAEVHVQQANQQL
Pep12p 195 QNLIEQRDQEISNIERGITELNEVFKDLGSVVQQQGVLVDNIEANIYTTSDNTQLASDEL
Tlg2p 244 EAYLRERDEEITQLARGVLEVSTIFREMQDLVVDQGTIVDRIDYNLENTVVELKSADKEL
Stx6 163 QLIVEQQDEQLELVSGSIGVLKNMSQRIGGELEEQAVMLDDFSHELESTQSRLDNVMKKL
Tlg1p 132 EQMLREQDVHLDGIHKTMQNLHIQAQTMGDELENQGQLLDNMDEGMDGVVNKLARGRRQL
Vam7p 250 MQMVRDQEQELVALHRIIQAQRGLALEMNEELQTQNELLTALEDDVDNTGRRLQIANKKA
Vti1p 124 HAILQKSGDRLKDASRIANETEGIGSQIMMDLRSQRETLENARQTLFQADSYVDKSIKTL
IcmG/DotF 146 GEQINAVNNNIKNLNAQIVNLNQIIGNMSNQIARQSEVINVLMARTTPKKVVKVSRPIVQ
CtrIncA-Nterm 92 YQDLQREVGSLKEINFMLSVLQKEFLHLSKEFATTSKDLSAVSQDFYSCLQGFRDNYKGF SNARE-
CtrIncA-Cterm 210 TVVIEELKTIRDSLRDEIGQLSQLSKTLTSQIALQRKESSDLCSQIRETLSSPRKSASPS like
CcaIncA-Nterm 126 VRHMKQQIQQFGEENTRLHTAVENLKAVNVELSEQINQLKQLHTRLSDFGDRLEANTGDF proteins
CcaIncA-Cterm 233 MSSVTELRTNLNALKELITENKTVIEQLKADAQLREEQVRFLEKRKQELEEACSTLSHSI
hSyb1 25 PPNMTS.NRRLQQTQAQVEEVVDIIRVNVDKVLERDQKLSELDDRADALQAGASQFESSA
hSyb2 22 PPNLTS.NRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSA
hSyb3 6 TAATGS.NRRLQQTQNQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSA
hVAMP8 2 EASEGGGNDRVRNLQSEVEGVKNIMTQNVERILARGENLEHLRNKTEDLEATSEHFKTTS R-SNAREs
Snc1p 20 PQNVQS.KSRTAELQAEIDDTVGIMRDNINKVAERGERLTSIEDKADNLAVSAQGFKRGA
Nyv1p 157 NGQNTI.SDIGDATEDQIKDVIQIMNDNIDKFLERQERVSLLVDKTSQLNSSSNKFRRKA
Sec22p 122 SYSDKKVQDNLDQLNQELVGVKQIMSKNIEDLLYRGDSLDKMSDMSSSLKETSKRYRKSA
mSec22b 126 YIDSRA.RRNLGSINTELQDVQRIMVANIEEVLQRGEALSALDSKANNLSSLSKKYRQDA
SNARE motifs from yeast and mammals were aligned with CtrIncA-N and C-term, CcaIncA-N and C-term and IcmG/DotF’s SNARE-like motifs (grey). The amino acids
indicating the layers in the heptad repeat are highlighted in bold (asterisk). Notice the conserved glutamine and arginine residues in the central ‘d’-position of the
heptad repeat, which constitute the zero layer. Stx = syntaxin. N-term and C-term refer to the N-terminal and C-terminal coiled-coil domain, respectively.
doi:10.1371/journal.pone.0007375.t001
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(Fig. 1B and 1C). We observed that the inhibitory effect of CtrIncA
correlates with its concentration in the liposomes (Fig. 1C and 1D).
Similarly, CcaIncA inhibits endocytic SNARE-mediated fusion
whether present on t-SNARE (,40% inhibition) or v-SNARE
liposomes (,50% inhibition) (Fig. 1G and 1F), confirming the
inhibitory role of IncA proteins. When we compared both the
effects of IncA and IcmG/DotF, a SNARE-like protein (Fig. 1H)
expressed by Legionella pneumophila [Table 1 and [18]], we also
observed inhibition of SNARE-mediated membrane fusion (Fig. 1).
Interestingly, IcmG/DotF has no effect when present on the
t-SNARE side (Fig. 1J), but only interferes with the v-SNARE
(Fig. 1I). Although both IncA and IcmG/DotF have a common
inhibitory function on membrane fusion, it appears that bacterial
SNARE-like proteins display different levels of efficiency. Most
likely, other SNARE-like proteins, such as LegC3, play a major
role in protecting Legionella’s vacuole [31].
Although CtrIncA has been previously implicated in homotypic
membrane fusion [22,23], we did not observe any fusion events
between CtrIncA-containing liposomes (data not shown). Perhaps
CtrIncA requires post-translational modifications such as phos-
phorylation, to become fusogenic [32]. Consistent with this
possibility, IncA has multiple phosphorylation sites that become
phosphorylated by host cells during infection [19,32]. Alterna-
tively, additional proteins from either Chlamydia or the host cell
might be necessary in combination with CtrIncA to promote
fusion. Interestingly, some non-fusogenic strains do express a
normal IncA protein on the inclusion membrane, supporting the
possibility that other elements of the fusion machinery are missing
in these strains [33].
We propose that CtrIncA could function as a switch to regulate
the maturation of the inclusion. During the infectious cycle of C.
trachomatis, each newly synthesized CtrIncA would first bind every
resident SNARE on the inclusion, until all are blocked. As a
consequence, SNARE-mediated fusion of the inclusion would be
totally inhibited. As CtrIncA continues to accumulate, excess
CtrIncA would then be available for further modification by the
host cell (phosphorylation) and/or for binding additional proteins.
CtrIncA would become active for fusion and inclusions could then
undergo homotypic fusion.
Next, we determined whether the inhibitory function was
encoded into the SNARE-like motif. Since IcmG/DotF has a
limited inhibitory effect, we concentrated our efforts on IncA.
IncA possesses two SNARE-like motifs [21] (Table 1, Fig. 1A). We
focused our attention on the N-terminal motif due to its presence
next to the trans-membrane domain mimicking the eukaryotic
SNARE configuration. This makes it ideally located to interact
directly with eukaryotic SNARE motifs. Furthermore, this motif
has previously been shown to be compatible with the formation of
a stable complex with SNARE proteins [19]. To determine
whether the N-terminal SNARE-like motif has an inhibitory
activity, truncated forms of CtrIncA were generated and their
effects on endocytic SNARE-mediated fusion were examined.
CtrIncA mutant containing only the N-terminal SNARE-like motif
(CtrIncA1–141) inhibited endocytic SNARE-mediated fusion in a
dose-dependent manner similar to the full-length protein (Fig. 2A).
Next, we delineated the minimal IncA sequence necessary to
retain the inhibitory function. As shown on Fig. 2B and Fig. 2C,
CtrIncA1–130 still displays a significant inhibitory effect (,15%,
p= 0.028) when present on either t- or v-SNARE membrane. On
the contrary, CtrIncA1–120, which contains only half of the
SNARE-like motif, completely lost its ability to inhibit endocytic
SNARE-mediated membrane fusion (Fig. 2D, 2E, p = 0.42). The
outcome was similar regardless of whether this truncated form of
IncA was reconstituted into t-SNARE or v-SNARE liposomes.
This suggests that the CtrIncA N-terminal SNARE-like motif
requires a SNARE-like motif of at least ,23 amino acids in order
to exert an effective inhibitory activity and confirm the role of this
motif in blocking membrane fusion. Although the function of the
C-terminal domain remains to be determined, we cannot exclude
its role in reinforcing the inhibitory effect of IncA.
Since Chlamydia inclusion membrane is derived from the plasma
membrane, we then decided to test the effect of both CtrIncA and
CcaIncA on the plasma membrane resident exocytic t-SNAREs
(Table 2). As shown in Fig. 3A, CtrIncA has no inhibitory effect on
any of the exocytic complexes tested, regardless of its concentra-
tion, suggesting that CtrIncA is specific for the endocytic SNAREs.
CcaIncA, on the other hand, exerts a significant inhibitory effect
on [Syn2/SNAP23], [Syn3/SNAP23] and [Syn4/SNAP23]
fusion (Fig. 3B), demonstrating that CcaIncA has a broader
inhibitory effect. These results further show that bacterial SNARE-
like proteins display different levels of specificity. One might
imagine that the capacity to inhibit a large range of membrane
fusion events could potentially increase the number of hosts that
intracellular bacteria could infect. For example, C. caviae has been
detected in a wide range of hosts [34]. Alternatively, blocking a
multitude of vesicular trafficking in the cells could impact the long-
term outcome of an infection. In particular it would be interesting
to correlate the level of SNARE-like protein inhibition with the
capacity of certain bacteria to induce chronic diseases.
To confirm SNARE-like proteins inhibitory function in a more
physiological environment, we tested IncA’s role in vivo in
mammalian cells that can potentially host infection. In order to
obtain quantitative results, we chose the RBL-2H3 mast cell line as
our model. Mast cells display a large number of endocytic
compartments, including their secretory granules, which are
secretory lysosomes [35]. During stimulation, the endocytic v-
SNAREs VAMP8 present on the secretory lysosomes bind the
exocytic t-SNAREs [Syntaxin 4/SNAP23] present on the plasma
membrane to mediate exocytosis [36,37]. If IncA interferes with
SNAREs when present in RBL-2H3 mast cells, as it does in the
liposomes, we should observe an inhibition of the secretory
pathway. Because CcaIncA full-length protein was toxic for the
cells, RBL-2H3 were transfected with myc-CcaIncA1–220, a
truncated form of CcaIncA still containing its SNARE-like
N-terminal domain [19], and therefore still inhibitory (see Fig. 2).
Myc-CcaIncA1–220 was cloned together with GFP into an IRES
vector to simultaneously express a transfection marker (40%
Table 2. SNARE proteins description.
SNARE investigated Category Location
Syntaxin7 t-SNARE Late endosome/lysosome
Syntaxin8 t-SNARE Late endosome/lysosome
Vti1b t-SNARE Late endosome/lysosome
VAMP8 v-SNARE Late endosome/lysosome
(mast cell secretory granules)
Syntaxin2 t-SNARE Plasma membrane
Syntaxin3 t-SNARE Plasma membrane
Syntaxin4 t-SNARE Plasma membrane
SNAP23 t-SNARE Plasma membrane
VAMP2 v-SNARE Secretory vesicle
The SNAREs involved in endocytosis are Syntaxin 7, Syntaxin 8, Vti1b and
VAMP8, while the SNAREs involved in exocytosis are Syntaxin 2, Syntaxin 3,
Syntaxin 4, SNAP23 and VAMP2.
doi:10.1371/journal.pone.0007375.t002
Bacterial i-SNAREs
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average transfection efficiency). Using immunofluorescence, we
observed that Myc-CcaIncA1–220 co-localized with lysotracker
(Fig. 4A), a marker of the RBL-2H3 secretory lysosomes [38]. This
suggests that Myc-CcaIncA1–220 is located on the secretory
lysosomes where it can potentially interact with the lysosomal
v-SNAREs VAMP8. This is physiologically relevant since VAMP8
is involved in the phagosomal fusion with lysosomes [39].
Therefore, interfering with VAMP8 would protect the phagosomal
compartment against degradation. After stimulating transfected
mast cells with both 1027M Phorbol 12-Myristate 13-Acetate
(PMA) and 1026M ionomycin, we analyzed the release of
b-hexosaminidase, a lysosomal enzyme stored inside mast cell
secretory lysosomes. Kinetic analyses showed that after 30 min of
stimulation, cells transfected with myc-CcaIncA1–220/GFP secrete
significantly less b-hexosaminidase than the GFP control. The
level of inhibition at 30 min (23% inhibition) and at 60 min (32%
inhibition) is significant (p,0.05 and p,0.02 respectively)
compared to GFP transfected cells (Fig. 4B). These data confirm
Figure 1. SNARE-like bacterial proteins inhibit endocytic SNARE-mediated membrane fusion. A- CtrIncA encodes a transmembrane
domain (aa34–82), a N-terminal (N-ter: aa107–145) and a C-terminal (C-ter: aa210–272) SNARE-like motif. B- VAMP8 was reconstituted with and without
CtrIncA into donor liposomes (coomassie gel), and incubated with t-SNARE liposomes containing [Syn7/Syn8/Vti1b]. Fusion decreases in presence of
CtrIncA (70% inhibition). C- t-[Syn7/Syn8/Vti1b] was reconstituted with different concentration of CtrIncA into acceptor liposomes. Fusion shows a
concentration dependency for CtrIncA inhibition. D- The percentage of inhibition with the standard deviation is plotted (n= 3). For each experiment,
results were normalized based on the fusion rate obtained after 2 hrs with the endocytic complex w/o CtrIncA (0x). We observed 20% inhibition for a
CtrIncA:Syn7 estimated ratio of 1:1 (1x). The inhibition rate increased to 35% for an estimated ratio of 2:1 (2x). E- CcaIncA encodes a transmembrane
domain (aa60–118), a N-terminal (N-ter: aa140–178) and a C-terminal (C-ter: aa233–295) SNARE-like motif. F-We observed 50% inhibition when CcaIncA
was reconstituted on the v-SNARE side with VAMP8. G- We observed 40% inhibition when CcaIncA was reconstituted with [Syn7/Syn8/Vti1b] into
acceptor liposomes. H- IcmG/DotF displays two hydrophobic regions (aa52–75 and 206–227), and a SNARE-like motif (aa146-210). I- Endocytic fusion is
reduced when IcmG/DotF is present in v-SNARE liposomes and the inhibition rate correlates with IcmG/DotF concentration, reaching 50% of inhibition
for an estimated ratio IcmG:VAMP8 of 1:2. J- IcmG/DotF does not interfere with membrane fusion when present in t-SNARE liposomes. All graphs are
representative of at least 3 independent experiments.
doi:10.1371/journal.pone.0007375.g001
Bacterial i-SNAREs
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the inhibitory effect of CcaIncA on t-[Syn4/SNAP23] and
v-[VAMP8]-mediated fusion previously observed using the
liposome fusion assay (Figs 3 and 1 respectively). Incidentally, this
also indicates that the in vitro liposome fusion assay is able to
accurately predict cellular data. Therefore, this assay represents a
unique system by which more bacterial proteins could be screened
for their effect on host vesicular trafficking.
Conclusion
The key for survival of intracellular bacteria in host cells is their
capacity to manipulate host cellular processes -in particular
membrane fusion- to allow the establishment of an intracellular
replicative niche. An obvious host machinery to target in order to
block membrane fusion is the SNARE machinery. Using CtrIncA,
CcaIncA and IcmG/DotF as our models, we demonstrated that
SNARE-like bacterial proteins differentially block SNAREs-
mediated membrane fusion. Furthermore, we showed that this
inhibitory function is encoded into their SNARE-like motifs,
validating the general function of such a motif for manipulating
membrane fusion.
Interestingly, clinical isolates lacking IncA present defects in
their infectious cycle, and the number of inclusions per cells is
significantly decreased [40,41]. This would suggests that the level
of protection exerted by Chlamydia cell wall during the first 8 hrs
[28] is sufficient for small inclusions to develop, but that IncA
synthesis is necessary for the inclusions to maturate further.
Alternatively, it could also suggest that additional protective
systems, although not as efficient IncA, are in place to insure such
an important function. Interestingly, Chlamydia was found to
express additional SNARE-like bacterial proteins, including
CT813, which also interacts with host SNARES [21]. Although
their inhibitory function remains to be confirmed, the redundancy
of the SNARE-like protein system would further support its
importance. Overlapping layers of protection would insure the
survival of Chlamydia in case one of the protective systems fails. The
differential timing of expression for each of these proteins could
also ensure the protection of the vacuole over time [30]. This
redundancy would explain the presence of a limited number of
Chlamydia inclusions during infections with strains naturally lacking
IncA [41]. Each SNARE-like protein may also be specific for a
Figure 2. The SNARE-like motif encodes the inhibitory function. A- Increasing concentrations of CtrIncA1–141 were reconstituted into
endocytic t-SNARE liposomes, and fusion proceeded in presence of VAMP8-liposomes. Fusion is significantly inhibited by the presence of CtrIncA1–141
and is dependent upon its concentration, reaching 55% of inhibition after 2 hrs with an estimated CtrIncA1–141:SNARE ratio of 2:1. This experiment is
representative of n = 3. B–E- Two different concentrations of truncated CtrIncA (see representative coomassie gels inserted in each graph) were
reconstituted into t-SNARE (B,D), and v-SNARE liposomes (C,E). As shown on graphs B and C, CtrIncA1–130 still displays a significant inhibitory effect on
the endocytic SNARE-mediated membrane fusion (average of 15% inhibition after 2 hrs, p = 0.022). On the contrary, CtrIncA1–120 (D,E) completely fails
to inhibit endocytic fusion (p.0.05). The mean from n=5 independent experiments was determined at 30 min, 60 min and 120 min. The standard
deviation is shown. One asterisk denotes statistically significant differences (p,0.05). For the purpose of comparison, maximal values of fusion
obtained for the SNARE complex without IncA at 120 min were arbitrarily defined as 100%.
doi:10.1371/journal.pone.0007375.g002
Bacterial i-SNAREs
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Figure 3. Bacterial SNARE-like proteins display different level of specificity. CtrIncA (A) and CcaIncA (B) were reconstituted with the
exocytic t-SNARE complexes [Syn2/SNAP23], [Syn3/SNAP23] and [Syn4/SNAP23]. After mixing t-SNARE liposomes (with or without IncA) with VAMP2
liposomes, fusion proceeded. Bar graphs represent the mean from n= 5 independent experiments at 30min, 60 min and 120 min for each of the
exocytic complex. For the purpose of comparison, maximal values of fusion obtained for the SNARE complex without IncA at 120 min were arbitrarily
defined as 100%. The standard deviation is shown. A- As shown on the curves and bar graphs, CtrIncA does not affect exocytic fusion regardless of its
concentration (p.0.05). B- After 2 hrs of fusion, CcaIncA significantly inhibits [Syn2/SNAP23]-mediated fusion by 35%, [Syn3/SNAP23]-mediated
fusion by 25% and [Syn4/SNAP23]-mediated fusion by 20% (p= 0.0079). One and two asterisks denote statistically significant differences with p,0.05,
and p,0.02 respectively.
doi:10.1371/journal.pone.0007375.g003
Bacterial i-SNAREs
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different set of host SNAREs, which would increase the protection
of the infectious vacuoles against a larger range of membrane
fusion events.
It is intriguing to notice that the inhibitory mechanism displayed
by bacterial SNARE-like proteins is very similar to the one
employed by the eukaryotic inhibitory-SNAREs (i-SNAREs).
SNARE-mediated fusion is triggered by four fusogenic subunits
and is highly specific [42,43,44,45]. It was shown that the presence
of a fifth SNARE on the same compartment could result in an
inhibition of fusion (therefore, such a SNARE has been called
inhibitory-SNARE). An i-SNARE can substitute for one of the
subunits of the functional tetramer leading to the formation of a
non-functional tetramer (acting as a pseudo t-SNARE) [46]. In the
Golgi, it has been demonstrated that a gradient of i-SNAREs
across cisternae blocks SNARE-mediated membrane fusion and is
likely used to fine-tune the specificity of membrane fusion [46].
Here we showed that bacterial SNARE-like proteins appear to
function in a similar fashion. Similar to i-SNAREs, these bacterial
proteins are capable to bind fusogenic SNAREs and inhibit
membrane fusion. Altogether, this suggests that coiled-coil
SNARE-like motifs may constitute one of the most effective motifs
to manipulate membrane fusion and has been incorporated into
intracellular bacteria genome as an adaptation to the pressures of
survival [47]. Ultimately, one could take advantage of such a
recurrence to develop a common therapeutic strategy for targeting
a wide array of bacterial SNARE-like proteins and revert the
fusion blockage.
Materials and Methods
DNA manipulation and plasmid construction
Standard genetic manipulations were performed throughout.
All polymerase chain reaction (PCR) procedures were done with
pfu turbo polymerase (Stratagene). All other DNA modifying
enzymes were from New England Biolabs. The E. coli strain DH5a
(Invitrogen) was used for standard cloning. Plasmid encoding
CcaIncA1˜22˜ was generated as described [19]. We added a myc tag
and cloned CcaIncA1˜22˜ into the pIRES2-EGFP vector (Clontech)
using the oligonucleotides FO134 GGGAATTCCATATGA-
CAGTATCCACAGACAACAC and FO135 CGGGATCCTCA-
CAGATCCTCTTCTGAGATGAGTTTTTGTTCCAAAGAC-
TGAGCTAATTTCT.
Plasmids encoding Syntaxin 2 (untagged), Syntaxin 3 (untagged),
Syntaxin 4 (untagged) and His6-SNAP23 were kindly provided by
Jingshi Shen (Columbia University, New York). Plasmids encoding
Syntaxin 7-His6, Syntaxin 8-His6, Vti1-His6 and VAMP8-His6 were
generated as described [45]. Plasmids encoding His6-CtrIncA and
His6-CcaIncA were generated as described in [19]. Plasmid encoding
His6-IcmG/DotF was generated by PCR using the oligonucleotides
FO117 GCGAATTCTCAACTATCTTCTTGACTAAACT and
FO118 GGGCATATCCATATGATGGCAGAGCACGATCA.
PCR fragments were subsequently ligated into the EcoRI-NdeI sites
of pET28a. Plasmids encoding His6-CtrIncA1–141, His6-CtrIncA1–130
and His6-CtrIncA1–120 were generated by PCR, respectively using
the oligonucleotides FO160 GGGCATATCCATATGACAAC-
GCCTACTCTAATCGTG and FO162 GATGGATCCCTAG-
TCTTTAGATGTCGTTGCAAAT; FO160 and FO163 GATG-
GATCCCTATAAATGAAGAAATTCTTTCTG. PCR fragments
were subsequently ligated into the NdeI-BamH1 sites of pET28a.
Figure 4. SNARE-like proteins inhibit intracellular fusion in
cells. A- Resting transfected RBL-2H3 cells were co-labeled with anti-
Myc Abs and lysotracker, and viewed by confocal microscopy. Myc-
CcaIncA1–220/GFP is on the left, while GFP control is on the right. Co-
localized Myc-CcaIncA1–220 and lysotracker compartments are indicated
with a yellow box and arrows. B-RBL-2H3 cells were transiently
transfected with Myc-CcaIncA1–220/GFP or with GFP alone. Total lysates
were migrated on SDS-PAGE and probed with Abs directed against
Myc. Equivalent amounts of protein in each lane was verified after
reprobing the blots with the anti-SNAP23. After stimulation of the
transfectants at different time points with 1027M PMA/1026M
ionomycin, the kinetics of degranulation was analyzed using the
b-hexosaminidase release assay. The mean of triplicates from five
independent experiments was determined. Standard errors are shown.
For the purpose of comparison, maximal values of degranulation
obtained for GFP-transfected cells at 60 min were arbitrarily defined as
100%. Transfection of Myc-CcaIncA1–220 (Grey bars) reduces mast cells
degranulation by 23% at 30 min and 31.8% at 60 min compared with
GFP (Dark bars). The asterisks denote statistically significant difference
(p,0.05) to GFP transfectants. Note that Myc-CcaIncA1–220/GFP and GFP
are not statistically different at 15 min (p = 0.26).
doi:10.1371/journal.pone.0007375.g004
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Protein expression and purification
VAMP8-His6, Syntaxin8-His6, Syntaxin7-His6 and Vti1b-His6
were expressed as described [45]. Plasma membrane t-SNARE
proteins Syntaxin3/His6-SNAP23, Syntaxin4/His6-SNAP23, Syn-
taxin 2/His6-SNAP23 were co-expressed in BL21 (DE3) star E. coli
(Invitrogen) and co-purified using the His6 tag present on
SNAP23.
All constructs derived from the bacterial proteins: CcaIncA-
His6, CtrIncA-His6, His6-CtrIncA1–141, His6-CtrIncA1–130, His6-
CtrIncA1–120 and IcmG/DotF-His6 were expressed in BL21 (DE3)
star E. coli for 12 hrs at 16uC to allow a proper folding of the
protein. All his-tagged proteins were purified using the procedure
previously described [44,45,48].
Reconstitution into liposomes
SNARE proteins were reconstituted into proteoliposomes by
detergent dilution and isolated on an Accudenz density gradient
flotation as previously described [6,49]. To insert bacterial
proteins into liposomes, v-SNARE protein and preformed t-
SNARE complexes were respectively preincubated with the
bacterial protein at different concentration for 4 hrs at 4uC,
before being mixed with the lipids, and dialysed for 16 hrs at 4uC.
Liposome fusion assay
Fusion reactions and data analysis were performed as previously
described [6,49]. For most fusion assays, the mean from at least 5
independent experiments was determined at 30 min, 60 min and
120 min. For the purpose of comparison, maximal values of fusion
obtained for the SNARE complex without IncA at 120 min were
arbitrarily defined as 100%. The Mann-Whitney U test was used
to compare the mean values of maximal fusion at 120 min
between SNARE-containing liposomes and SNARE/IncA-con-
taining liposomes. Significance was assumed at p values,0.05.
Cell transfection
The rat mast cell line RBL-2H3 was cultured as described [37].
We used the AMAXA nucleofector technology (AMAXA,
Germany) to transiently transfect the RBL-2H3 cells. Briefly,
26106 cells were nucleofected in 100 ml solution V (AMAXA)
using 1 mg of pIRES2-EGFP-CcaIncA1˜22˜ vector or pIRES2-EGFP
vector (control). The cells were nucleofected using the program
T-030. Cells were then plated in complete medium in 96 well
plates for subsequent secretory cell assays 12 hrs later. Using these
conditions, the efficiency of transfection was routinely in the range
of 30 to 40% as determined by immunofluorescence (GFP
positive).
Confocal immunofluorescence microscopy
Lysotracker labeling was performed following the manufacturer’s
instruction. Briefly, cells grown on coverslips were incubated with
lysotracker 1:20,000 for 20 min in complete medium and washed
three times. The Myc tag labeling was performed as described [37].
We used the anti-myc antibody (9E10) from Santa Cruz
Biotechnology. Cy5-conjugated anti-mouse antibody was from
Jackson Laboratories. All data were analyzed using a Leica TCS SP
confocal microscope, LEICA CONFOCAL 2.5 software, HCX PL
APO 63X oil immersion objective.
Secretory cell assay
Transfectants were plated in 96 well plates in triplicates at
,56105 cells in 100 ml of complete DMEM medium and
incubated overnight at 37uC. After 12 hrs, adherent RBL cells
were washed twice in prewarmed phenol red free DMEM and
stimulated by Phorbol Myristate Acetate (1027M)/ionomycin
(1026M). At different time points (0, 15 min, 30 min 1 hr), 25 ml
of supernatant was collected and the granule secretion marker
b-hexosaminidase was analyzed using test supernatants within
the linear range of the assay [50]. Total cellular content of
b-hexosaminidase was determined by lysis of the adherent cells in
0.5% Triton X-100. The absorbance was determined at 410 nm
in a micro-titer plate reader. Results were calculated as a
percentage of total b-hexosaminidase in cells after correction for
spontaneous release in unstimulated cultures. For the purpose of
comparison, all data were normalized to the maximal value of
b-hexosaminidase release obtained in pIRES2-EGFP transfectants
and arbitrarily taken as 100%. The Mann-Whitney U test was
used to compare the mean values of maximal release between GFP
and Myc-CcaIncA 1–220 transfectants. Significance was assumed at
p values,0.05.
SDS-PAGE and Western blot analysis
Western blots were performed as described [51]. The anti-myc
antibody (9E10) was from Santa Cruz Biotechnology, the anti-
SNAP23 antibody from Synaptic System and both were used at
1:500. The secondary antibodies were from Biorad and were used
at 1:20,000.
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